We are live on
!
Find out more
CC
Cederberg Capital Portfolio holdings
AUM
$100M
1-Year Est. Return
90.57%
This Fund
S&P 500
This Quarter
Est. Return
-2.22%
1 Year Est. Return
+90.57%
3 Year Est. Return
+273.33%
5 Year Est. Return
+52.55%
10 Year Est. Return
–
AUM
$294M
AUM Growth
-$6.74M
(-2.2%)
Cap. Flow
+$6.08M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NBP
NovaBridge Biosciences American Depositary Shares
NBP
|
+$9.26M |
| 2 |
GDS Holdings
GDS
|
+$622K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 55.39% |
| 2 | Communication Services | 31.14% |
| 3 | Technology | 13.47% |
| 4 | Healthcare | 0% |
Similar funds
AM
TFG
SIRP
SIC
APA
SHU
APGDR
GC
Cederberg Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Cederberg Capital held 6 positions worth $294M, down 2.2% from $301M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Cederberg Capital's Q1 2023 filing shows 1 increased, 1 reduced and 1 closed positions. The largest sale was NovaBridge Biosciences American Depositary Shares, an estimated $9.26M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 55% of assets, down from 56% a quarter earlier, followed by Communication Services and Technology.
- Cederberg Capital added most to JD.com in Q1 2023, an estimated $16M increase.
- Cederberg Capital's biggest Q1 2023 reduction was GDS Holdings, cutting an estimated $622K.
- Cederberg Capital fully exited NovaBridge Biosciences American Depositary Shares in Q1 2023, selling an estimated $9.26M.
- Cederberg Capital's ten largest holdings make up 100% of its $294M portfolio in Q1 2023.
- Cederberg Capital opened 0 new positions and closed 1 in Q1 2023.
- Cederberg Capital's portfolio value fell 2.2% quarter-over-quarter to $294M.
Based on Cederberg Capital's 13F filing for Q1 2023, filed 15 May 2023.